MedPath

CLOFARABINE

These highlights do not include all the information needed to use CLOFARABINE INJECTION safely and effectively. See full prescribing information for CLOFARABINE INJECTION. CLOFARABINE injection, for intravenous use. Initial U.S. Approval: 2004

Approved
Approval ID

e956b1e0-2829-4872-8c09-99462d60e922

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 15, 2023

Manufacturers
FDA

Fosun Pharma USA Inc.

DUNS: 080920998

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CLOFARABINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72266-108
Application NumberANDA207831
Product Classification
M
Marketing Category
C73584
G
Generic Name
CLOFARABINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 15, 2023
FDA Product Classification

INGREDIENTS (3)

CLOFARABINEActive
Quantity: 1 mg in 1 mL
Code: 762RDY0Y2H
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLOFARABINE - FDA Drug Approval Details